New CFSE-based assay to determine susceptibility to lysis by cytotoxic T cells of leukemic precursor cells within a heterogeneous target cell population - PubMed (original) (raw)
. 2004 Apr 1;103(7):2677-82.
doi: 10.1182/blood-2003-06-2070. Epub 2003 Nov 20.
Affiliations
- PMID: 14630824
- DOI: 10.1182/blood-2003-06-2070
Free article
New CFSE-based assay to determine susceptibility to lysis by cytotoxic T cells of leukemic precursor cells within a heterogeneous target cell population
Inge Jedema et al. Blood. 2004.
Free article
Abstract
For the clinical evaluation of the efficacy of cellular immunotherapy it is necessary to analyze the effector functions of T cells against primary leukemic target cell populations which are usually considerably heterogeneous caused by differential maturation stages of the leukemic cells. An appropriate assay should not only allow the quantitative analysis of rapid cell death induction as measured by the conventional 51Cr release assay but also of the more slowly executing pathways of T-cell-induced apoptosis occurring within days instead of hours which cannot be measured using this method. Furthermore, it should dissect the differential susceptibility to T-cell-induced cell death of various target cell subpopulations and characterize the malignant precursor cells capable of producing malignant progeny. To fulfill these requirements we developed a new assay based on carboxyfluorescein diacetate succinimidyl ester (CFSE) labeling of the target cell population combined with antibody staining of specific cell populations and addition of fluorescent microbeads to quantitatively monitor target cell death occurring within a longer time frame up to at least 5 days. This new assay facilitates the analysis of differential recognition of distinct cell types within a heterogeneous target cell population and allows simultaneously evaluation of the proliferative status of surviving target cells in response to relevant cytokines.
Similar articles
- Tracing tolerance and immunity in vivo by CFSE-labeling of administered cells.
Ingulli E. Ingulli E. Methods Mol Biol. 2007;380:365-76. doi: 10.1007/978-1-59745-395-0_23. Methods Mol Biol. 2007. PMID: 17876106 Review. - Carboxyfluorescein succinimidyl ester-based proliferative assays for assessment of T cell function in the diagnostic laboratory.
Fulcher D, Wong S. Fulcher D, et al. Immunol Cell Biol. 1999 Dec;77(6):559-64. doi: 10.1046/j.1440-1711.1999.00870.x. Immunol Cell Biol. 1999. PMID: 10571678 - Carboxyfluorescein diacetate succinimidyl ester and the virgin lymphocyte: a marriage made in heaven.
Fazekas de St Groth B, Smith AL, Koh WP, Girgis L, Cook MC, Bertolino P. Fazekas de St Groth B, et al. Immunol Cell Biol. 1999 Dec;77(6):530-8. doi: 10.1046/j.1440-1711.1999.00871.x. Immunol Cell Biol. 1999. PMID: 10571674 Review.
Cited by
- Depletion of phagocytic myeloid cells triggers spontaneous T cell- and NK cell-dependent antitumor activity.
Guth AM, Hafeman SD, Dow SW. Guth AM, et al. Oncoimmunology. 2012 Nov 1;1(8):1248-1257. doi: 10.4161/onci.21317. Oncoimmunology. 2012. PMID: 23243588 Free PMC article. - Immunopeptidome mining reveals a novel ERS-induced target in T1D.
Wang L, Yang S, Zhu G, Li J, Meng G, Chen X, Zhang M, Wang S, Li X, Pan Y, Huang Y, Wang L, Wu Y. Wang L, et al. Cell Mol Immunol. 2024 Jun;21(6):604-619. doi: 10.1038/s41423-024-01150-0. Epub 2024 Apr 30. Cell Mol Immunol. 2024. PMID: 38689020 - A combined approach of human leukocyte antigen ligandomics and immunogenicity analysis to improve peptide-based cancer immunotherapy.
Peper JK, Stevanović S. Peper JK, et al. Cancer Immunol Immunother. 2015 Oct;64(10):1295-303. doi: 10.1007/s00262-015-1682-8. Epub 2015 Mar 31. Cancer Immunol Immunother. 2015. PMID: 25822767 Free PMC article. Review. - Leukemia-associated minor histocompatibility antigen discovery using T-cell clones isolated by in vitro stimulation of naive CD8+ T cells.
Bleakley M, Otterud BE, Richardt JL, Mollerup AD, Hudecek M, Nishida T, Chaney CN, Warren EH, Leppert MF, Riddell SR. Bleakley M, et al. Blood. 2010 Jun 10;115(23):4923-33. doi: 10.1182/blood-2009-12-260539. Epub 2010 Mar 4. Blood. 2010. PMID: 20203263 Free PMC article. - Human-Induced CD49a+ NK Cells Promote Fetal Growth.
Du X, Zhu H, Jiao D, Nian Z, Zhang J, Zhou Y, Zheng X, Tong X, Wei H, Fu B. Du X, et al. Front Immunol. 2022 Feb 4;13:821542. doi: 10.3389/fimmu.2022.821542. eCollection 2022. Front Immunol. 2022. PMID: 35185911 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical